Skip to main content
. 2019 Feb 22;17(4):3009–3014. doi: 10.3892/etm.2019.7295

Table II.

Changes in related indexes to blood glucose and lipid metabolisms in both groups at 1 week and 1 month after treatment (mean ± SD).

Group Treatment Fasting blood glucose (mmol/l) 2 h postprandial blood glucose (mmol/l) Insulin resistance Triglyceride (mmol/l) Total cholesterol (mmol/l)
Observation group 1 week after treatment 7.9±0.3 9.9±0.5 1.3±0.1 2.12±0.08 5.39±0.15
1 month after treatment 5.6±0.2a,b 7.5±0.3a,b 1.1±0.11a,b 1.56±0.07a,b 3.69±0.08a,b
Control group 1 week after treatment 8.0±0.4 10.0±0.5 1.4±0.1 2.13±0.09 5.40±0.16
1 month after treatment 6.5±0.3a 8.5±0.61a 1.3±0.11a 1.96±0.061a 5.23±0.101a
t1 40.345 26.032 8.944 33.318 62.129
p1 <0.001 <0.001 <0.001 <0.001 <0.001
t2 18.974 12.147 4.472 9.940 5.698
p2 <0.001 <0.001 <0.001 <0.001 <0.001
t3 15.787 9.428 8.944 27.440 76.055
p3 <0.001 <0.001 <0.001 <0.001 <0.001
a

P<0.05 vs. observation group and control group at 1 week after treatment

b

P<0.05 vs. control group at 1 week after treatment. t1, the results of comparison in observation group between 1 month after treatment and 1 week after treatment. t2, the results of comparison in observation group between 1 month after treatment and 1 week after treatment. t3, the results of comparison between observation group and control group at 1 month after treatment.